US20150374631A1 - Pharmaceutical Formulation Containing Gelling Agent - Google Patents

Pharmaceutical Formulation Containing Gelling Agent Download PDF

Info

Publication number
US20150374631A1
US20150374631A1 US14/846,021 US201514846021A US2015374631A1 US 20150374631 A1 US20150374631 A1 US 20150374631A1 US 201514846021 A US201514846021 A US 201514846021A US 2015374631 A1 US2015374631 A1 US 2015374631A1
Authority
US
United States
Prior art keywords
dosage form
controlled release
release oral
gelling agent
oral dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
US14/846,021
Inventor
Curtis Wright
Benjamin Oshlack
Christopher Breder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Purdue Pharma LP
Original Assignee
Purdue Pharmaceuticals LP
PF Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to US31053401P priority Critical
Priority to US10/214,412 priority patent/US20030068375A1/en
Priority to US12/653,115 priority patent/US20100168148A1/en
Priority to US13/349,449 priority patent/US8337888B2/en
Priority to US13/726,324 priority patent/US9060976B2/en
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29218415&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20150374631(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority to US14/243,580 priority patent/US20140213606A1/en
Priority to US14/728,601 priority patent/US20150283250A1/en
Application filed by Purdue Pharmaceuticals LP, PF Laboratories Inc filed Critical Purdue Pharmaceuticals LP
Priority to US14/846,021 priority patent/US20150374631A1/en
Publication of US20150374631A1 publication Critical patent/US20150374631A1/en
Assigned to PURDUE PHARMA L.P. reassignment PURDUE PHARMA L.P. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: PURDUE PHARMA TECHNOLOGIES, INC., THE P.F. LABORATORIES, INC.
Application status is Pending legal-status Critical

Links